AAPL 188.99 -0.13 (-0.07%)MSFT 128.09 -0.03 (-0.02%)FB 185.32 +0.01 (+0.01%)ZNGA 6.19 -0.01 (-0.16%)NVDA 156.55 +0.3 (+0.19%)WBA 52.27 -0.05 (-0.09%)GOOG 1161.8 -0.53 (-0.05%)PIH 5.82 +0.25 (+4.49%)
AAPL 188.99 -0.13 (-0.07%)MSFT 128.09 -0.03 (-0.02%)FB 185.32 +0.01 (+0.01%)ZNGA 6.19 -0.01 (-0.16%)NVDA 156.55 +0.3 (+0.19%)WBA 52.27 -0.05 (-0.09%)GOOG 1161.8 -0.53 (-0.05%)PIH 5.82 +0.25 (+4.49%)

Discounted Cash Flow (DCF) Analysis Levered

KalVista Pharmaceuticals Inc. Quote

KalVista Pharma (KALV)

23.89 0.04 Healthcare
All | Free Cash Flow | Weighted Average Cost Of Capital | Build Up Free Cash | Terminal Value | Intrinsic Value | Results |

Free Cash Flow KALV Quote KalVista Ph

Weighted Average Cost Of Capital KALV Quote KalVista Ph

Share Price $ 23.89
Diluted Shares Outstanding 0
Cost of Debt
Tax Rate -
After-tax Cost of Debt -
Risk Free Rate
Market Risk Premium
Cost of Equity 21.88
Total Debt 0.00
Total Equity 23.89
Total Capital 23.89
Debt Weighting 0.00
Equity Weighting 100.00
Wacc

Build Up Free Cash Flow KALV Quote KalVista Ph

Terminal Value KALV Quote KalVista Ph

Growth in perpetuity method:
Long term growth rate
WACC (%) 21.9
Free cash flow (t+1) 0.00
Terminal Value 0.00
Present Value of Terminal Value 0.00

Intrinsic Value KALV Quote KalVista Ph

Enterprise Value -
Net Debt -22
Equity Value -
Shares Outstanding 1
Equity Value Per Share -

Results Levered DCF KALV Quote KalVista Ph